155 related articles for article (PubMed ID: 80297)
1. Gamma heavy chain disease in man: synthesis of a deleted gamma3 immunoglobulin by lymphoid cells in short and long term tissue culture.
Buxbaum JN; Alexander A; Olivier O
Clin Exp Immunol; 1978 Jun; 32(3):489-97. PubMed ID: 80297
[TBL] [Abstract][Full Text] [Related]
2. Articular, monoclonal gamma3 heavy-chain deposition disease: characterization of a partially deleted heavy-chain gene and its protein product synthesized in vivo and in vitro.
Thompson KM; Sletten K; Brandtzaeg P; Källberg E; Wien TN; Husby G
Arthritis Rheum; 2003 Nov; 48(11):3266-71. PubMed ID: 14613292
[TBL] [Abstract][Full Text] [Related]
3. Celluar immunoglobulins in human gamma- and alpha-heavy chain diseases.
Preud'homme JL; Brouet JC; Seligmann M
Clin Exp Immunol; 1979 Aug; 37(2):283-91. PubMed ID: 115628
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal IgM cryoglobulinemia associated with gamma-3 heavy chain disease: immunochemical and biochemical studies.
Wang AC; Arnaud P; Fudenberg HH; Creyssel R
Eur J Immunol; 1978 Jun; 8(6):375-9. PubMed ID: 97087
[TBL] [Abstract][Full Text] [Related]
5. Murine heavy chain disease.
Morrison SL
Eur J Immunol; 1978 Mar; 8(3):194-9. PubMed ID: 95958
[TBL] [Abstract][Full Text] [Related]
6. Further studies on an eleventh case of heavy (Hgamma1) chain disease--biosynthetic studies.
Arima T; Miyamoto-Sudo C; Hiroata M; Tanigawa T; Tsuboi S
Acta Med Okayama; 1975 Jun; 29(3):225-31. PubMed ID: 127516
[TBL] [Abstract][Full Text] [Related]
7. Multiple genomic defects result in an alternative RNA splice creating a human gamma H chain disease protein.
Guglielmi P; Bakhshi A; Cogne M; Seligmann M; Korsmeyer SJ
J Immunol; 1988 Sep; 141(5):1762-8. PubMed ID: 3137265
[TBL] [Abstract][Full Text] [Related]
8. Biosynthetic and structural studies of a heavy chain disease protein.
Ein D; Buell DN; Fahey JL
J Clin Invest; 1969 Apr; 48(4):785-93. PubMed ID: 4180120
[TBL] [Abstract][Full Text] [Related]
9. Gamma heavy chain disease. Ultrastructural and immunohistochemical study.
Abe M; Wakasa H; Mori N; Kojima M
Acta Pathol Jpn; 1983 Jul; 33(4):689-700. PubMed ID: 6414241
[TBL] [Abstract][Full Text] [Related]
10. [Gamma-heavy chain disease associated with MALT lymphoma of the duodenum].
Ieko M; Kohno M; Ohmoto A; Notoya A; Fukazawa Y; Yasukouchi T; Sawada K; Koike T
Rinsho Ketsueki; 1998 Jul; 39(7):512-8. PubMed ID: 9750459
[TBL] [Abstract][Full Text] [Related]
11. Gamma-heavy chain disease. Preliminary studies in three cases.
Ouchterlony O; Lindholm L; Lönnroth I; Westin J
Ann Immunol Hung; 1972; 16(0):303-8. PubMed ID: 4137680
[No Abstract] [Full Text] [Related]
12. Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature.
Fermand JP; Brouet JC; Danon F; Seligmann M
Medicine (Baltimore); 1989 Nov; 68(6):321-35. PubMed ID: 2509855
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and biosynthetic studies of a crystallizable human gamma 1 heavy-chain disease protein.
Mihaesco E; Guglielmi P; Brouet JC; Mihaesco C
Scand J Immunol; 1983 Aug; 18(2):145-52. PubMed ID: 6410498
[TBL] [Abstract][Full Text] [Related]
14. A new case of gamma heavy chain disease: clinical, immunochemical and structural characterization.
Carbonara AO; Paolino W; Malavasi F; Levis A; Stramignoni A; de Lange G; van Loghem E; Franklin EC
Vox Sang; 1979; 37(2):89-95. PubMed ID: 91266
[TBL] [Abstract][Full Text] [Related]
15. Alpha and gamma heavy chain diseases in man: intracellular origin of the aberrant polypeptides.
Buxbaum JN; Preud'homme JL
J Immunol; 1972 Nov; 109(5):1131-7. PubMed ID: 4116764
[No Abstract] [Full Text] [Related]
16. [Gamma heavy chain disease during rheumatoid polyarthritis. Immunocytologic study].
Jacqueline F; Micouin C; Léger J; Brambilla E; Groulade J
Rev Rhum Mal Osteoartic; 1979; 46(7-9):499-503. PubMed ID: 116361
[No Abstract] [Full Text] [Related]
17. [Gamma heavy chain disease associated with rheumatoid arthritis. Spontaneous disappearance of the pathologic protein].
Gaucher A; Bertrand F; Brouet JC; Pourel J; Netter P; Faure G; Seligmann M
Sem Hop; 1977 Nov; 53(38):2117-20. PubMed ID: 204020
[TBL] [Abstract][Full Text] [Related]
18. Gamma heavy chain disease in man: independent structural abnormalities and reduced transcription of a functionally rearranged lambda L-chain gene result in the absence of L-chains.
Teng MH; Rosen S; Gorny MK; Alexander A; Buxbaum J
Blood Cells Mol Dis; 2000 Jun; 26(3):177-85. PubMed ID: 10950937
[TBL] [Abstract][Full Text] [Related]
19. The structural heterogeneity among degraded gamma heavy chain disease proteins.
Franklin EC
J Immunol; 1978 Dec; 121(6):2582-3. PubMed ID: 102697
[TBL] [Abstract][Full Text] [Related]
20. Gene mutations and alternate RNA splicing result in truncated Ig L chains in human gamma H chain disease.
Cogné M; Bakhshi A; Korsmeyer SJ; Guglielmi P
J Immunol; 1988 Sep; 141(5):1738-44. PubMed ID: 3137264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
